A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

NCT05598268 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Lung Cancer
Liver Cancer
Lymphoma
Mesothelioma of Pleura

Interventions

BIOLOGICAL: T3011

Sponsor

ImmVira Pharma Co. Ltd